Redwood City, CA, United States of America

Chi-Sing Ho

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Tempus Ai, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chi-Sing Ho. Retrieved from https://idiyas.com/inventor/chi-sing-ho-10fuc69l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Chi-Sing Ho

Introduction

Chi-Sing Ho is a notable inventor based in Redwood City, CA. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 2 patents, his work focuses on enhancing the understanding and treatment of cancer through advanced imaging and machine learning techniques.

Latest Patents

Chi-Sing Ho's latest patents include a platform for co-culture imaging to characterize in vitro efficacy of heterotypic effector cellular therapies in cancer. This method involves providing a panel of different combinations of cancer organoid cells and immune cells to culturing wells. The different combinations are cultured under conditions that support organoid growth. Brightfield and corresponding fluorescence images of the culturing wells are captured and analyzed by trained machine learning algorithms. These algorithms identify and distinguish cancer organoid cells from immune cells, characterizing the morphological changes caused by immune cell-based therapies. An analytical report is generated, detailing the characterization of cancer organoid cell death caused by the therapy.

Another significant patent is related to systems and methods for deconvolving cell types in histology slide images using super-resolution spatial transcriptomics data. This computer-implemented method involves receiving training data to train a machine learning model that generates a cell expression map. The method processes histology images and cell segmentation maps using the trained model, enhancing the accuracy of cell type identification in histological studies.

Career Highlights

Chi-Sing Ho is currently employed at Tempus AI, Inc., where he continues to push the boundaries of cancer research. His work is instrumental in developing innovative solutions that leverage technology to improve patient outcomes.

Collaborations

Chi-Sing collaborates with talented individuals such as Ameen Salahudeen and Tianyou Luo, contributing to a dynamic research environment that fosters innovation.

Conclusion

Chi-Sing Ho's contributions to cancer research through his patents exemplify the intersection of technology and medicine. His innovative approaches are paving the way for advancements in cancer therapies and diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…